Home › Funds › Knoll Capital Management, LLC › PHAR

Knoll Capital Management, LLC position in PHAR

PHARMING GROUP NV · Health Care

Knoll Capital Management, LLC reported holding 4,091 shares of PHAR (PHARMING GROUP NV) in its Q2 2026 13F filing — a position valued at US$57K, representing 0.03% of its reported portfolio and ranking #36 among its reported holdings. Knoll Capital Management, LLC has disclosed PHAR holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)4.09K sh
Reported value held$56.82K
Portfolio Weight0.03%
First reportedQ1 2026
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Knoll Capital Management, LLC's PHAR position evolved

Knoll Capital Management, LLC first disclosed a stake in PHAR in Q1 2026 at 4,057 shares (US$68K). Across 2 filings, Knoll Capital Management, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 4,091 shares valued at US$57K — an increase of 34 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2026 4.06K $67.51K New
Q2 2026 4.09K $56.82K Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PHAR and 13F data

PHAR (PHARMING GROUP NV) is a Health Care company. 15 other funds we track also report a position in PHAR — the largest reported positions include Silverberg Bernstein Capital Management LLC (US$358K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PHAR

All PHAR fund holders →

FAQ

How long has Knoll Capital Management, LLC held PHAR?

Knoll Capital Management, LLC has disclosed PHAR holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Knoll Capital Management, LLC's current position in PHAR?

As of Q2 2026, Knoll Capital Management, LLC holds 4.09K shares of PHAR (PHARMING GROUP NV), valued at $56.82K, representing 0.03% of its reported portfolio and ranking #36.

Has Knoll Capital Management, LLC been buying or selling PHAR?

In the latest 13F filing (Q2 2026), Knoll Capital Management, LLC increased its position in PHAR.

Which other funds hold PHAR?

Other major institutional holders of PHAR include Silverberg Bernstein Capital Management LLC, among 15 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.